360 NEWS360 NEWS
Home / Business

Rhythm Pharmaceuticals’ obesity drug cuts BMI by up to 18.8% in two-year trial

Long-term trial findings presented at ObesityWeek 2026 showed sustained reductions in body mass index among patients receiving the therapy.

Published
Original News Source The Hindu BusinessLine
Content & Media Rights The Hindu BusinessLine
Editorial Publisher 360 NEWS (Independent Media)
Rhythm Pharmaceuticals’ obesity drug cuts BMI by up to 18.8% in two-year trial
Photo / Source: The Hindu BusinessLine
Long-term trial findings presented at ObesityWeek 2026 showed sustained reductions in body mass index among patients receiving the therapy.

Editorial & Syndication Notice: This story has been syndicated or published by 360 NEWS in accordance with verified fair-use, official press dissemination, and original attribution protocols. All trademarks, photos, and referenced quotes remain the property of their respective owners. For editorial corrections, press inquiries, or rights notices, contact [email protected].